Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113214764 | 11321476 | 4 | F | 20150713 | 20160724 | 20150729 | 20160724 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-048453 | BRISTOL MYERS SQUIBB | 61.00 | YR | M | Y | 0.00000 | 20160724 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113214764 | 11321476 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 70 MG, Q3WK | Y | N | 21986 | 70 | MG | Q3W | |||||
| 113214764 | 11321476 | 2 | SS | SPRYCEL | DASATINIB | 1 | Oral | 20MG | Y | N | 21986 | 20 | MG | TIW | |||||
| 113214764 | 11321476 | 3 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | Oral | 25 MG, UNK | U | 0 | 25 | MG | |||||||
| 113214764 | 11321476 | 4 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | U | 0 | ||||||||||
| 113214764 | 11321476 | 5 | C | MS CONTIN | MORPHINE SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 113214764 | 11321476 | 6 | C | OXYCODONE | OXYCODONE | 1 | Unknown | U | 0 | ||||||||||
| 113214764 | 11321476 | 7 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113214764 | 11321476 | 1 | Chronic myeloid leukaemia |
| 113214764 | 11321476 | 3 | Product used for unknown indication |
| 113214764 | 11321476 | 4 | Product used for unknown indication |
| 113214764 | 11321476 | 5 | Product used for unknown indication |
| 113214764 | 11321476 | 6 | Product used for unknown indication |
| 113214764 | 11321476 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113214764 | 11321476 | OT |
| 113214764 | 11321476 | HO |
| 113214764 | 11321476 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113214764 | 11321476 | Cardiac failure congestive | |
| 113214764 | 11321476 | Coma | |
| 113214764 | 11321476 | Fluid retention | |
| 113214764 | 11321476 | Off label use | |
| 113214764 | 11321476 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113214764 | 11321476 | 1 | 20110605 | 0 | ||
| 113214764 | 11321476 | 2 | 20110516 | 0 |